Sickle cell scholar component

镰状细胞学者组件

基本信息

  • 批准号:
    7843557
  • 负责人:
  • 金额:
    $ 24.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-23 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

This proposal describes the career development plan for the proposed Sickle Cell Scholar. The next generation of clinical researchers in sickle cell disease (SCD) will need to include individuals with the skills, attitudes, early research training and experience to capitalize on rapidly developing progress in SCD research. In developing this plan, we will use established research infrastructure, including our Graduate Training Program in Clinical Investigation (GTPCI) at the Johns Hopkins University School of Medicine and Johns Hopkins University Bloomberg School of Public Health and a mentored research project to provide intensive training in clinical research and methodology for the Sickle Cell Scholar. Our specific aims are: a) To identify, train and develop a creative and successful clinical investigator, with the capability to interact with, participate in, and lead multidisciplinary teams involved in clinical research, address complex problems and become a national leader in SCD research; b) To provide the trainee with the requisite skills, knowledge, attitude and experience for a successful career in clinical research in SCD. This training will include exposure to national and international leaders and curriculum in the multiple disciplines necessary for successful clinical research, including clinical trials design, epidemiology, statistics, research ethics and human subjects protection, as well as a research project developed by the Scholar in conjunction with his mentor; c) To provide access to the rich mentoring environment of the Johns Hopkins University School of Medicine and School of Public Health to provide optimal exposure of the Sickle Cell Scholar to research experiences and training. Careful and extensive mentoring will be the cornerstone of this effort, with exposure to and involvement in cutting edge research. Through this program, we ultimately aim to develop a Sickle Cell Scholar, who will become a creative, independent investigator, care for patients with SCD and assume a leadership role in SCD patient-oriented research.
本计划书描述了镰状细胞学者的职业发展计划。接下来的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James F Casella其他文献

MODULATION OF THE IMMUNE RESPONSE TO HPA-1A by CTLA4-Ig. † 896
  • DOI:
    10.1203/00006450-199604001-00918
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Emily A Barron-Casella;William M Baldwin;Thomas S Kickler;James F Casella
  • 通讯作者:
    James F Casella
798 ACTIN UNDERGOES RAPID AND REVERSIBLE POLYMERIZATION ASSOCIATED WITH PLATELET SHAPE CHANGE
798 肌动蛋白经历与血小板形状改变相关的快速且可逆的聚合。
  • DOI:
    10.1203/00006450-198104001-00822
  • 发表时间:
    1981-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    James F Casella;Shin Lin;William H Zinkham
  • 通讯作者:
    William H Zinkham

James F Casella的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James F Casella', 18)}}的其他基金

Hydroxyurea to Prevent the Central Nervous System Complications of Sickle Cell Disease in Children
羟基脲预防儿童镰状细胞病中枢神经系统并发症
  • 批准号:
    9810412
  • 财政年份:
    2019
  • 资助金额:
    $ 24.39万
  • 项目类别:
Hydroxyurea to Prevent CNS Complications of Sickle Cell Disease in Children
羟基脲预防儿童镰状细胞病中枢神经系统并发症
  • 批准号:
    8865963
  • 财政年份:
    2014
  • 资助金额:
    $ 24.39万
  • 项目类别:
Hydroxyurea to Prevent CNS Complications of Sickle Cell Disease in Children
羟基脲预防儿童镰状细胞病中枢神经系统并发症
  • 批准号:
    8144680
  • 财政年份:
    2011
  • 资助金额:
    $ 24.39万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7843558
  • 财政年份:
    2009
  • 资助金额:
    $ 24.39万
  • 项目类别:
Longitudinal SIT Trial Plasma Proteomic Biomarker Discovery and Validation in SCI
SCI 中的纵向 SIT 试验血浆蛋白质组生物标志物的发现和验证
  • 批准号:
    7555939
  • 财政年份:
    2008
  • 资助金额:
    $ 24.39万
  • 项目类别:
Longitudinal SIT Trial Plasma Proteomic Biomarker Discovery and Validation in SCI
SCI 中的纵向 SIT 试验血浆蛋白质组生物标志物的发现和验证
  • 批准号:
    8005533
  • 财政年份:
    2008
  • 资助金额:
    $ 24.39万
  • 项目类别:
Longitudinal SIT Trial Plasma Proteomic Biomarker Discovery and Validation in SCI
SCI 中的纵向 SIT 试验血浆蛋白质组生物标志物的发现和验证
  • 批准号:
    7761227
  • 财政年份:
    2008
  • 资助金额:
    $ 24.39万
  • 项目类别:
Comprehensive Sickle Cell Center at JHU and UAB
约翰霍普金斯大学和阿拉巴马大学综合镰状细胞中心
  • 批准号:
    7843559
  • 财政年份:
    2008
  • 资助金额:
    $ 24.39万
  • 项目类别:
Comprehensive Sickle Cell Center at JHU and UAB
约翰霍普金斯大学和阿拉巴马大学综合镰状细胞中心
  • 批准号:
    7640587
  • 财政年份:
    2008
  • 资助金额:
    $ 24.39万
  • 项目类别:
Clinical Hematology Research Career Development Program (K12) at Hopkins
霍普金斯大学临床血液学研究职业发展计划 (K12)
  • 批准号:
    8464193
  • 财政年份:
    2006
  • 资助金额:
    $ 24.39万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 24.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了